Vaccination responses to capsular polysaccharides of Neisseria meningitidis and Haemophilus influenzae type b in two C2-deficient sisters: Alternative pathway-mediated bacterial killing and evidence for a novel type of blocking IgG

Journal of Clinical Immunology

Volumn 20, Issue 2, 2000, Pages 138-149

  Selander, Barbro ^a   Käyhty, Helena ^b   Wedege, Elisabeth ^c   Holmström, Eva ^a   Truedsson, Lennart ^a   Söderström, Claes ^d   Sjöholm, Anders G ^a,d  

^a Institute of Laboratory Medicine   (Sweden)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bacteria; Complement; Immunodeficiency diseases; Infectious immunity; Vaccination

Indexed keywords

BACTERIAL POLYSACCHARIDE; COMPLEMENT COMPONENT C2; DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN G; MENINGOCOCCUS VACCINE;

ADOLESCENT; ARTICLE; BACTERIAL MEMBRANE; BACTERIAL MENINGITIS; BACTERICIDAL ACTIVITY; CASE REPORT; COMPLEMENT DEFICIENCY; COMPLEMENT SYSTEM; CONTROLLED STUDY; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; VACCINATION;

ADOLESCENT; ANTIBODIES, BLOCKING; ANTIGENS, CD44; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; CHILD, PRESCHOOL; COMPLEMENT C2; COMPLEMENT PATHWAY, ALTERNATIVE; FEMALE; GENETIC MARKERS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; IMMUNOGLOBULIN G; MEMBRANE GLYCOPROTEINS; MENINGITIS, HAEMOPHILUS; MENINGITIS, MENINGOCOCCAL; MITOCHONDRIAL PROTEINS; NEISSERIA MENINGITIDIS; OPSONIN PROTEINS; PHAGOCYTOSIS; POLYSACCHARIDES, BACTERIAL; RECEPTORS, COMPLEMENT; SEROTYPING; VACCINES, INACTIVATED;

EID: 0034066740     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006638631581     Document Type: Article

References (52)

1. 1. Ross SC, Densen P: Complement deficiency states and infection: Epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine (Baltimore) 63:243-273, 1984
2. 2. Figueroa JE, Densen P: Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 4:359-395, 1991
3. 3. Yu CY: Molecular genetics of the human MHC complement gene cluster. Exp Clin Immunogenet 15:213-230, 1998
4. 4. Johnson CA, Densen P, Hurford RK Jr, Colten HR, Wetsel RA: Type I human complement C2 deficiency. A 28-base pair gene deletion causes skipping of exon 6 during RNA splicing. J Biol Chem 267:9347-9353, 1992
5. 5. Truedsson L, Alper CA, Awdeh ZL, Johansen P, Sjöholm AG, Sturfelt G: Characterization of type I complement C2 deficiency MHC haplotypes. Strong conservation of the complotype/HLA-B region and absence of disease association due to linked class II genes. J Immunol 151:5856-5863, 1993
6. 6. Sjöholm AG: Inherited complement deficiency states: implications for immunity and immunological disease. APMIS 98:861-874, 1990
7. 7. Pangburn MK, Müller-Eberhard HJ: The alternative pathway of complement. Springer Semin Immunopathol 7:163-192, 1984
8. 8. Ratnoff WD, Fearon DT, Austen KF: The role of antibody in the activation of the alternative complement pathway. Springer Semin Immunopathol 6:361-371, 1983
9. 9. Valim YML, Lachmann PJ: The effect of antibody isotype and antigenic density on the complement-fixing activity of human immune complexes: A system study using chimaeric anti-NIP antibodies with human Fc regions. Clin Exp Immunol 84:1-8, 1991
10. 10. Steuer KLK, Sloan LB, Oglesby TJ, Farries TC, Nickells MW, Densen P, Harley JB, Atkinson JP: Lysis of sensitized sheep erythroctes in human sera deficient in the second component of complement. J Immunol 143:2256-2261, 1989
11. 11. Söderström C, Braconier JH, Käyhty H, Sjöholm AG, Thuresson B: Immune response to tetravalent meningococcal vaccine: Opsonic and bactericidal functions of normal and properdin deficient sera. Eur J Clin Microbiol Infect Dis 8:220-224, 1989
12. 12. Sjöholm AG, Selander B, Östenson S, Holmström E, Söderström C: Normal human serum depleted of C1q, factor D and properdin: Its use in studies of complement activation. APMIS 99:1120-1128, 1991
13. 13. Fredlund H, Sjöholm AG, Selander B, Holmström E, Olcén P, Danielsson D: Serum bactericidal activity and induction of chemiluminescence of polymorphonuclear leukocytes: Complement activation pathway requirements in defense against N. meningitidis. Int Arch Allergy Immunol 100:135-143, 1993
14. 14. Muscher D, Gorce A, Murphy T, Chapman A, Zahradnik J, Apicella M, Baughn R: Immunity to Haemophilus influenzae type b in young adults: Correlation of bactericidal and opsonizing activity of serum with antibody to polyribosylribitol phosphate and lipooligosaccharide before and after vaccination. J Infect Dis 154:935-943, 1986
15. 15. Steele NP, Munson RS Jr, Granoff DM, Cummins JE, Levine RP: Antibody-dependent alternative pathway killing of Haemophilus influenzae type b. Infect Immun 44:452-458, 1984
16. 16. Densen P, Weiler JM, Griffiss JM, Hoffmann LG: Familial properdin deficiency and fatal meningococcemia. Correction of the bactericidal defect by vaccination. N Engl J Med 316:922-926, 1987
17. 17. Fijen CAP, Kuijper EJ, Drogari-Apiranthitou M, van Leeuwen Y, Daha MR: Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine. Clin Exp Immunol 114:362-364, 1998
18. 18. Andreoni J, Käyhty H, Densen P: Vaccination and the role of capsular polysaccharide antibody in prevention of recurrent meningococcal disease in late complement component-deficient individuals. J Infect Dis 168:227-231, 1993
19. 19. Umetsu DT, Ambrosino DM, Quinti I, Siber GR, Geha RS: Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency. N Engl J Med 313:1247-1251, 1985
20. 20. Ambrosino DM, Schiffman G, Gotschlich EC, Schur PH, Rosenberg GA, DeLange GG, van Loghem E, Siber GR: Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria. J Clin Invest 75:1935-1942, 1985
21. 21. Sarvas H, Rautonen N, Sipinen S, Mäkelä O: IgG subclasses of pneumococcal antibodies - Effect of allotype G2m(n). Scand J Immunol 29:229-237, 1989
22. 22. Olcén P, Danielsson D, Kjellander J: The use of protein A containing staphylococci sensitized with antimeningococcal antibodies for grouping Neisseria meningitidis and demonstration of meningococcal antigen in cerebrospinal fluid. Acta Pathol Microbiol Scand (B) 83:387-396, 1975
23. 23. Abdillahi H, Poolman JT: Whole cell ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol Lett 48:367-371, 1987
24. 24. Wedege E, Hoiby EA, Rosenqvist E, Froholm LO: Serotyping and subtyping of Neisseria meningitidis isolates by co-agglutination, dot-blotting and ELISA. J Med Microbiol 31:195-201, 1990
25. 25. Ray JG Jr. Hare DB, Pedersen PD, Mulally DI: NIAID Manual of Tissue Typing Techniques. Bethesda, MD, Department of Health, Education and Welfare, National Institute of Health, 1976.
26. 26. Truedsson L. Sjöholm AG, Laurell A-B: Screening for deficiences of the classical and alternative pathways of complement by hemolysis in gel. Acta Pathol Microbiol Scand (C) 89:161-166, 1981
27. 27. Nilsson UR, Nilsson B: Simplified assays of hemolytic activity of the classical and alternative complement pathways. J Immunol Methods 72:49-59, 1984
28. 28. Johnson U. Truedsson L. Gustavii B: Complement components in 100 newborns and their mothers determined, by electroimmunoassay. Acta Pathol Microbiol Immunol Scand (C) 91:147-150, 1984
29. 29. Grubb A: Quantitation of immunoglobulin G by electrophoresis in agarose gel containing antibodies. Scand J Clin Lab Invest 26: 249-255, 1970
30. 30. Grubb A: Crossed immunoelectrophoresis and electroimmunoassay of IgM. J Immunol 112:1420-1425, 1974
31. 31. Grubb R, Klein G, Levine PH: Burkitt lymphoma and genetic markers of immunoglobulins. Exp Clin Immunogenet 3:125-128, 1986
32. 32. Rautonen N. Seppälä I, Hallberg T. Grubb R, Mäkelä O: Determination of homozygosity or heterozygosity for the G2m(n) allotype by a monoclonal, precipitating antibody. Exp Clin Immunogenet 6:31-37, 1989
33. 33. Platonov AE, Beloborodev VB, Pavlova LI, Vershinina IV, Käyhty H: Vaccination of patients deficient in a late complement component with tetravalent meningococcal capsular polysaccharide vaccine. Clin Exp Immunol 100:32-39, 1995
34. 34. Käyhty H, Eskola J, Peltola H, Stout M, Samuelson JS, Gordon LK: Immunogenicity in infants of a vaccine composed of Haemophilus influenzae type b capsular polysaccharide mixed with DPT or conjugated to diphteria toxoid. J Infect Dis 155:100-106, 1987
35. 35. Barrera O, Swanson J: Antigens that are similar in apparent molecular weight to gonococcal outer membrane protein III. J Clin Microbiol 25:1155-1158, 1987
36. 36. Söderström C, Braconier JH, Sjöholm AG, Thuresson B: Granulocyte functions and Neisseria meningitidis: Influence of properdin-deficient serum. APMIS 99:965-971, 1991
37. 37. Junker A, Baatrup G, Svehag S-E, Wang P, Holmström E, Sturfelt G, Sjöholm AG: Binding of properdin to solid-phase immune complexes: Critical role of the classical activation pathway of complement. Scand J Immunol 47:481-486, 1998
38. 38. Käyhty H, Eskola J, Peltola H, Rönnberg P-R, Kela RN, Karanko V, Saarinen L: Antibody responses to four Haemophilus influenzae type b conjugate vaccines. Am J Dis Child 145:223-227, 1991
39. 39. Rice PA, Vayo HE, Tam MR, Blake MS: Protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum. J Exp Med 164:1735-1748, 1986
40. 40. Munkley A, Tinsley CR, Virji M, Heckels JE: Blocking of bactericidal killing of Neisseria meningitidis by antibodies directed against class 4 outer membrane protein. Microb Pathog 11:447-452, 1991
41. 41. Schlesinger M, Greenberg R, Levy J, Käyhty H, Levy R: Killing of meningococci by neutrophils: Effect of vaccination on patients with complement deficiency. J Infect Dis 170:449-553, 1994
42. 42. Edwards MS, Kasper DL, Nicholson-Weller A, Baker CJ: The role of complement in opsonization of CBS. In Neonatal Group B Streptococcal Infections, KK Christensen, P Christensen, P Ferrieri (eds). Basel, S Karger, 1985, pp 170-189
43. 43. Ochs HD, Nonoyama S, Zhu Q. Farrington M, Wedgwood RJ: Regulation of antibody responses: the role of complement and adhesion molecules. Clin Immunol Immunopathol 67:33-40, 1993
44. 44. O'Neil KM, Ochs HD, Heller SR, Cork LC, Morris JM, Winkelstein JA: Role of C3 in humoral immunity. Defective antibody production in C3-deficient dogs. J Immunol 140:1939-1945, 1988
45. 45. Alper CA, Colten HR, Gear JSS, Rabson AR, Rosen FS: Homozygous human C3 deficiency. The role of C3 in antibody production, CIs-induced vasopermeability, and cobra venom-induced passive hemolysis. J Clin Invest 57:222-229, 1976
46. 46. Steeghs L, Kuipers B, Hamstra HJ, Kersten G, van Alphen L, van der Ley P: Immunogenicity of outer membrane proteins in a lipopolysaccharide-deficient mutant of Neisseria meningitidis: Influence of adjuvants on the immune response. Infect Immun 67:4988-4993, 1999
47. 47. Drogari-Aparanthitou M, Fijen CAP, Thiel S, Platonov A, Jensen L, Dankert J, Kuijper EJ: The effect of mannan-binding lectin on opsonophagocytosis of Neisseria meningitidis. Immunopharmacology 38:93-99, 1997
48. 48. van Emmerik LC, Kuijper EJ, Fijen CAP, Dankert J, Thiel S: Binding of mannan-binding protein to various bacterial pathogens of meningitis. Clin Exp Immunol 97:411-416, 1994
49. 49. Jack DL, Dodds AW, Anwer N, Ison CA, Law A, Frosch M, Turner MW, Klein NJ: Activation of complement by mannosebinding lectin on isogenic mutants of Neisseria meningitidis serogroup B. J Immunol 160:1346-1353, 1998
50. 50. Schlesinger M, Mashal U, Levy J, Fishelson Z: Hereditary properdin deficiency in three families of Tunisian Jews. Acta Paediatr 82:744-747, 1993
51. 51. Jarvis GA, Griffiss JM: Human IgA1 blockade of IgG-initiated lysis of Neisseria meningitidis is a function of antigen-binding fragment binding to the polysaccharide capsule. J Immunoi 147: 1962-1967, 1991
52. 52. Maslanka SE, Tappero JW, Plikaytis BD, Brumberg RS, Dykes JK, Gheesling LL, Donaldson KBJ, Schuchat A, Pullman J, Jones M, Bushmaker J, Carlone GM: Age-dependent Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titer in sera from young children from Montana immunized with a licensed polysaccharide vaccine. Infect Immun 66:2453-2459, 1998